REGISTERED NUMBER: 15316256 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 December 2025

for

Venipharm Ltd

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

E Mauger

SECRETARY:

Pramex International Ltd

REGISTERED OFFICE:

8th Floor South

11 Old Jewry

London

EC2R 8DU

REGISTERED NUMBER:

15316256 (England and Wales)

CURRENT ASSETS

Debtors

4

468,712

166,073

Cash at bank

75,593

128,159

544,305

294,232

CREDITORS

Amounts falling due within one year

5

495,370

282,430

NET CURRENT ASSETS

48,935

11,802

TOTAL ASSETS LESS CURRENT LIABILITIES

48,935

11,802

CAPITAL AND RESERVES

Called up share capital

10,000

10,000

Retained earnings

38,935

1,802

SHAREHOLDERS' FUNDS

48,935

11,802

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 25 June 2026 and were signed by:

E Mauger - Director

1.	STATUTORY INFORMATION

Venipharm Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Amount are rounded to the nearest £.

Going concern

The company is dependent upon the continued financial support of its parent company

which has undertaken to financially support the company for the at least 12 months after the

date of the signing of these accounts and for the foreseeable future.

The financial statements have therefore been prepared on a going concern basis.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

4.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.25

31.12.24

£

£

Trade debtors

82,962

-

Amounts owed by group undertakings

306,152

155,482

Other debtors

79,598

10,591

468,712

166,073

5.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.25

31.12.24

£

£

Trade creditors

36,347

13,745

Amounts owed to group undertakings

409,506

242,023

Taxation and social security

12,732

927

Other creditors

36,785

25,735

495,370

282,430

6.	RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland, not to disclose related party transactions with wholly owned subsidiaries within the group.

7.	ULTIMATE CONTROLLING PARTY

The immediate parent undertaking is Calonne SAS, a company registered in France. The

address of its registered office is 4 Bureaux de la colline, Saint cloud, France, 92210.